Effects of a one-week fasting therapy in patients with type-2 diabetes mellitus and metabolic syndrome—a randomized controlled explorative study
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
There is increasing experimental evidence for beneficial effects of calorie restriction and intermittent fasting in type 2 diabetes mellitus (T2DM). In humans, prolonged fasting is established as a health-promoting complementary treatment in Europe and claimed to improve metabolism by a complex hormetic response. We aimed to investigate effects of a one-week fasting period compared to usual care in T2DM by means of a pilot trial. Patients with manifest T2DM medically treated with oral hypoglycemic agents and/or insulin were randomly assigned to a 7-day fasting program followed by dietary advice or to usual care and dietary advice only. Fasting was performed according to the method of Buchinger with a nutritional energy intake of 300kcal/day by liquids only and stepwise re-introduction of solid food thereafter. Outcomes were assessed baseline and after 4 months. Of 46 enrolled participants, 32 (n=16 each group) completed the trial and were included for final analyses. Fasting was well accepted, there were no serious adverse events. After 4 months mean weight decreased by 3.5 kg and 2.0 kg in the fasting vs. control group (p=0.03) paralleled by greater reduction of abdominal circumference (p=0.001). Fasting led to a significant decrease of systolic/diastolic blood pressure (p=0.01; p=0.003) and increased quality-of-life (p=0.04), while for HbA1c, insulin and HOMA-index only non-significant improvements were observed. Results of this study suggest that prolonged fasting is feasible and might have beneficial clinical effects. The effectiveness of fasting should be proved in larger confirmatory trials that include intermittent fasting in follow-ups to enable more pronounced and long-term effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387 · cited 1×
“Furthermore, IF may elicit changes in the gut microbiota that protects against metabolic syndromes [20].”
BackgroundFasting: molecular mechanisms and clinical applications
Longo, V. D., & Mattson, M. P. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2013.12.008 · Cited by 1,425 · cited 2×
“, stimulation of the HPA-axis that may be interpreted as a hormetic stress reaction [1, 21].”
BackgroundBrandhorst, S., Choi, I. Y., Wei, M., Cheng, C. W., Sedrakyan, S., Navarrete, G., Dubeau, L., Yap, L. P., Park, R., Vinciguerra, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.012 · Cited by 850
Meal frequency and timing in health and disease
Mattson, M. P., Allison, D. B., Fontana, L., Harvie, M., Longo, V. D., Malaisse, W. J., Mosley, M., Notterpek, L., Ravussin, E., Scheer, F. A. J. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413965111 · Cited by 531
Larson-Meyer, D. E., Heilbronn, L. K., Redman, L. M., Newcomer, B. R., Frisard, M. I., Anton, S., Smith, S. R., Alfonso, A., Ravussin, E., & the Pennington CALERIE Team (2006) · Diabetes Care · doi:10.2337/dc05-2565 · Cited by 504
Steven, S., Hollingsworth, K. G., Al-Mrabeh, A., Avery, L., Aribisala, B., Caslake, M., & Taylor, R. (2016) · Diabetes Care · doi:10.2337/dc15-1942 · Cited by 418 · cited 1×
“700 kcal/day) [12, 13] the weight loss and metabolic effect of the one-week fasting therapy were rather modest.”
BackgroundWeiss, E. P., Racette, S. B., Villareal, D. T., Fontana, L., Steger-May, K., Schechtman, K. B., Klein, S., & Holloszy, J. O. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.5.1033 · Cited by 353
Health effects of intermittent fasting: hormesis or harm? A systematic review
Horne, B. D., Muhlestein, J. B., & Anderson, J. L. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.109553 · Cited by 239
Warkentin, L. M., Das, D., Majumdar, S. R., Johnson, J. A., & Padwal, R. S. (2014) · Obesity Reviews · doi:10.1111/obr.12113 · Cited by 198
Martin, C. K., Bhapkar, M., Pittas, A. G., Pieper, C. F., Das, S. K., Williamson, D. A., Scott, T., Redman, L. M., Stein, R., Gilhooly, C. H., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.1189 · Cited by 198
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Wilhelmi de Toledo, F., Grundler, F., Bergouignan, A., Drinda, S., & Michalsen, A. (2019) · PLOS ONE · doi:10.1371/journal.pone.0209353 · Cited by 239
“It was also found in two previous smaller studies using Buchinger fasting [49, 50].”
ResultSelf-citationMaifeld, A., Bartolomaeus, H., Löber, U., Avery, E. G., Steckhan, N., Markó, L., Wilck, N., Hamad, I., Šušnjar, U., Mähler, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22097-0 · Cited by 201
Self-citationMeng, H., Zhu, L., Kord-Varkaneh, H., O Santos, H., Tinsley, G. M., & Fu, P. (2020) · Nutrition · doi:10.1016/j.nut.2020.110801 · Cited by 146
International consensus on fasting terminology
Koppold, D. A., Breinlinger, C., Hanslian, E., Kessler, C., Cramer, H., Khokhar, A. R., Peterson, C. M., Tinsley, G., Vernieri, C., Bloomer, R. J., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.06.013 · Cited by 107
Self-citationObermayer, A. M., Tripolt, N. J., Pferschy, P. N., Kojzar, H., Aziz, F., Müller, A., Schauer, M., Oulhaj, A., Aberer, F., Sourij, C., et al. (2022) · Diabetes Care · doi:10.2337/dc22-1622 · Cited by 135
“(12) also reported data from a 7-day fasting program with a maximum intake of 300 kcal to reduce body weight in participants with type 2 diabetes; however,”
BackgroundBorgundvaag, E., Mak, J., & Kramer, C. K. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa926 · Cited by 101
Nicoll, R., & Henein, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030751 · Cited by 78
“Both randomised controlled trials [21,22] and non-randomised studies [20,23–26] of CR have shown that it can lower systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure in male and female type 2 diabetics and non-diabetics compared to a standard diet.”
BackgroundHammer, S. S., Vieira, C. P., McFarland, D., Sandler, M., Levitsky, Y., Dorweiler, T. F., Lydic, T. A., Asare‐Bediako, B., Adu-Agyeiwaah, Y., Sielski, M. S., et al. (2021) · Diabetologia · doi:10.1007/s00125-021-05431-5 · Cited by 105
“The beneficial effects of fasting in improving metabolic health, warding off chronic disease and increasing longevity have been established by several well-designed clinical trials; however, the data on IF in diabetic individuals remain limited [48, 49] and potential risks associated with IF in people with diabetes ha…”
BackgroundEffects of Periodic Fasting on Fatty Liver Index—A Prospective Observational Study
Drinda, S., Grundler, F., Neumann, T., Lehmann, T., Steckhan, N., Michalsen, A., & Wilhelmi de Toledo, F. (2019) · Nutrients · doi:10.3390/nu11112601 · Cited by 84
“These results are in line with a previous study on periodic fasting in T2DM [31].”
BackgroundResultSelf-citationMorales-Suarez-Varela, M., Collado Sánchez, E., Peraita-Costa, I., Llopis-Morales, A., & Soriano, J. M. (2021) · Nutrients · doi:10.3390/nu13093179 · Cited by 84
“with obesity and people with type 2 diabetes [17,24,29].”
BackgroundMethodInfluentialRajpal, A., & Ismail‐Beigi, F. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14080 · Cited by 70
Dietary patterns and cardiometabolic health: Clinical evidence and mechanism
Wang, W., Liu, Y., Li, Y., Luo, B., Lin, Z., Chen, K., & Liu, Y. (2023) · MedComm · doi:10.1002/mco2.212 · Cited by 100
Horne, B. D., Grajower, M. M., & Anderson, J. L. (2020) · JAMA · doi:10.1001/jama.2020.3908 · Cited by 71
Dietary interventions in blood pressure lowering: current evidence in 2020
Strilchuk, L. M., Cincione, R. I., Fogacci, F., & Cicero, A. F. G. (2020) · Kardiologia Polska · doi:10.33963/kp.15468 · Cited by 72
Laurens, C., Grundler, F., Damiot, A., Chery, I., Le Maho, A., Zahariev, A., Le Maho, Y., Bergouignan, A., Gauquelin‐Koch, G., Simon, C., et al. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12766 · Cited by 52
Yang, F., Liu, C., Liu, X., Pan, X., Li, X., Tian, L., Sun, J., Yang, S., Zhao, R., An, N., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.669325 · Cited by 52
Epigenetic Regulation of Metabolism and Inflammation by Calorie Restriction
Hernández‐Saavedra, D., Moody, L., Xu, G. B., Chen, H., & Pan, Y. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy129 · Cited by 57
Real-Hohn, A., Navegantes, C., Ramos, K., Ramos-Filho, D., Cahuê, F., Galina, A., & Salerno, V. P. (2018) · PLOS ONE · doi:10.1371/journal.pone.0202784 · Cited by 43
Vitale, R., & Kim, Y. (2020) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2020.0048 · Cited by 43
“33 The Buchinger fasting method and control group demonstrated similar decreases in insulin resistance as measured by HOMA-IR, but the reduction was not significant between groups ( - 1.5 – 4.6 Buchinger vs. - 1.5 – 2.1 control).”
InfluentialInsulin resistance in Alzheimer’s disease: The genetics and metabolomics links
Amin, A. M., Mostafa, H. M. A., & Khojah, H. M. J. (2022) · Clinica Chimica Acta · doi:10.1016/j.cca.2022.12.016 · Cited by 52
Silva, A. I., Direito, M., Pinto‐Ribeiro, F., Ludovico, P., & Sampaio‐Marques, B. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12113699 · Cited by 49
“For each study, the square represents the mean difference between baseline and fasting conditions, with the horizontal line intersecting it as the lower and upper limits of the 95% confidence interval [9,22,23,25,29,32,34,43,47,54,61].”
BackgroundMethodInfluentialEfficacy of Fasting in Type 1 and Type 2 Diabetes Mellitus: A Narrative Review
Herz, D., Haupt, S., Zimmer, R. T., Wachsmuth, N. B., Schierbauer, J., Zimmermann, P., Voit, T., Thurm, U., Khoramipour, K., RILSTONE, S. K., et al. (2023) · Nutrients · doi:10.3390/nu15163525 · Cited by 49
“[78] demonstrated that people with T2DM who underwent a one-week prolonged fasting program using Buchinger’s method showed a mean 3.”
MethodLong-term fasting improves lipoprotein-associated atherogenic risk in humans
Grundler, F., Plonné, D., Mesnage, R., Müller, D., Sirtori, C. R., Ruscica, M., & de Toledo, F. W. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02578-0 · Cited by 47
“Moreover, the lipoprotein lipase activity was not, measured: the insulin drop during fasting [27, 67] could reduce the insulindependent activity of the enzyme.”
BackgroundFasting intervention and its clinical effects on the human host and microbiome
Forslund, S. K. (2022) · Journal of Internal Medicine · doi:10.1111/joim.13574 · Cited by 39
Muñóz-Hernández, L. L., Márquez-López, Z., Mehta, R., & Aguilar-Salinas, C. A. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1295-2 · Cited by 39
Dai, Z., Zhang, H., Wu, F., Chen, Y., Yang, C., Wang, H., Sui, X., Guo, Y., Xin, B., Zhifeng, G. U. O., et al. (2022) · Nutrients · doi:10.3390/nu14183860 · Cited by 39
“Following the decrease of blood glucose, a significant decline of HbA1c and HOMA-IR was observed throughout the fasting experiment (Figure 5b,d), whereas one-week Buchinger fasting did not significantly decrease HbA1c and HOMA-index in a pilot study of type 2 diabetes patient [42].”
BackgroundKord‐Varkaneh, H., Nazary-Vannani, A., Mokhtari, Z., Salehi‐Sahlabadi, A., Rahmani, J., Clark, C. C. T., Fatahi, S., Zanghelini, F., Hekmatdoost, A., Okunade, K. S., et al. (2020) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-020-00391-0 · Cited by 39
Efficacy and safety of prolonged water fasting: A narrative review of human trials
Ezpeleta, M., Cienfuegos, S., Lin, S., Pavlou, V., Gabel, K., & Varady, K. A. (2024) · Nutrition Reviews · doi:10.1093/nutrit/nuad081 · Cited by 32
Jose, R., Syed, F., Thomas, A., & Toma, M. (2024) · Applied Sciences · doi:10.3390/app14052132 · Cited by 43
“Interventions such as fasting, low-calorie diets, exercise, and behavioral psychological therapy have all shown benefits in lowering blood glucose levels in studies assessing their effects in patients with diabetes [17–21].”
BackgroundKirkham, A. A., Beka, V., & Prado, C. M. M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.06.029 · Cited by 32
Mechanisms underlying the effects of caloric restriction on hypertension
Attar, A. A., Fahed, G., Hoballah, M. M., Pedersen, S., EL‐Yazbi, A. F., Nasser, S. A., Bitto, A., Orekhov, A. N., & Eid, A. H. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115035 · Cited by 37
“…this significant effect of CR in humans was reported in studies of different designs including cross-sectional [14-16] randomized controlled [17,18] and non-randomized [19-23] studies in both men and women with variable baseline characteristics with subjects being obese, overweight,…”
Intermittent fasting protects β-cell identity and function in a type-2 diabetes model
Patel, S., Yan, Z., & Remedi, M. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155813 · Cited by 36
Sharma, S. K., Mudgal, S. K., Kalra, S., Gaur, R., Thakur, K., & Agarwal, R. K. (2023) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2023.19.1.25 · Cited by 45
“…of outcome assessment (detection bias) Incomplete outcome data (attrition bias) Carter et al. 2016 Carter et al. 2018 Wing et al. 1994 Wing et al. 1991 Sundfor et al. 2018 Li et al. 2017 Kahleova et al. 2014 Cienfuegos et al. 2020 Corley et al. 2018 Harvie et al. 2013 Williams et al. 1998 + ?”
Intervenção educativa na qualidade de vida e conhecimento da síndrome metabólica
Santos, I. S. C., de Araújo, W. A., Damaceno, T. D. O., Souza, A. D. S., Boery, R. N. S. D. O., & Fernandes, J. D. (2022) · Acta Paulista de Enfermagem · doi:10.37689/acta-ape/2022ao02982 · Cited by 29
van den Burg, E. L., van Peet, P. G., Schoonakker, M. P., van de Haar, D. E., Numans, M. E., & Pijl, H. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad015 · Cited by 34
Xiao, Y., Liu, Y., Zhao, L., & Zhou, Y. (2022) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2022.0014 · Cited by 26
Intermittent Fasting: Myths, Fakes and Truth on This Dietary Regimen Approach
Brogi, S., Tabanelli, R., Puca, S., & Calderone, V. (2024) · Foods · doi:10.3390/foods13131960 · Cited by 26
Intermittent Fasting: Myths, Fakes and Truth on this Dietary Regimen Approach
Brogi, S., Tabanelli, R., Puca, S., & Calderone, V. (2024) · doi:10.20944/preprints202405.1820.v1 · Cited by 26
Medical nutrition therapy for the management of type 2 diabetes mellitus
Barrea, L., Verde, L., Colao, A., Mandarino, L. J., & Muscogiuri, G. (2025) · Nature Reviews Endocrinology · doi:10.1038/s41574-025-01161-5 · Cited by 33
Xiaoyu, W., Yuxin, X., & Li, L. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1325894 · Cited by 32
Ng, G. Y.-Q., Kang, S.-W., Kim, J., Shaik, A. A., Baik, S., Jo, D., Hande, M. P., Sobey, C. G., Gunaratne, J., Fann, D. Y., et al. (2019) · Dose-Response · doi:10.1177/1559325819876780 · Cited by 24
“Hydrogen sulfide is an important gaseous modulator reported to be a key factor in protecting against various liver diseases.(28,29) Moreover, IF16 also seemed to induce expression of genes that modulate metabolic processes such as carbohydrate and lipid homeostasis.”
BackgroundFatahi, S., Nazary-Vannani, A., Sohouli, M. H., Mokhtari, Z., Kord-Varkaneh, H., Moodi, V., Tan, S. C., Low, T. Y., Zanghelini, F., & Shidfar, F. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1798350 · Cited by 22
Tavakoli, A., Akhgarjand, C., Ansar, H., Houjaghani, H., Khormani, A., Djafarian, K., Rostamian, A., Ranjbar, M., & Farsani, G. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-86734-0 · Cited by 29
Dietary Risk Factors and Eating Behaviors in Peripheral Arterial Disease (PAD)
Cecchini, A. L., Biscetti, F., Rando, M. M., Nardella, E., Pecorini, G., Eraso, L. H., DiMuzio, P. J., Gasbarrini, A., Massetti, M., & Flex, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810814 · Cited by 37
“Furthermore, the decrease in systolic and diastolic pressure during periods of fasting leads to the easier management of hypertension, thus improving cardiovascular risk and quality of life [64].”
BackgroundHuang, Y., Zheng, Q., Yang, H., Fu, X., Zhang, X., Xia, C., Zhu, Z., Liu, Y., & Liu, W. J. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4851671 · Cited by 19
Koppold, D. A., Klatte, C., Demmrich, S., Schwarz, J., Kandil, F. I., Steckhan, N., Ring, R. M., Keßler, C. S., Jeitler, M., Koller, B., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.662310 · Cited by 17
Self-citationKoppold, D. A., Kandil, F. I., Güttler, O., Müller, A., Steckhan, N., Meiß, S., Breinlinger, C., Nelle, E., Hartmann, A. M., Jeitler, M., et al. (2023) · Nutrients · doi:10.3390/nu15122695 · Cited by 16
“The safety and feasibility of fasting therapies have been shown for other indications, such as rheumatoid arthritis, fibromyalgia syndrome, diverse cardiometabolic conditions, and type 2 diabetes mellitus [7,30,38,43].”
BackgroundSelf-citationEl ayuno intermitente y sus efectos en la salud metabólica en humanos
de Carvajal, V. M., Marín, A., Gihardo, D., Maluenda, F., Carrasco, F., & Chamorro, R. (2023) · Revista médica de Chile · doi:10.4067/s0034-98872023000100081 · Cited by 22
Intermittent fasting in the management of diabetes: a review of glycemic control and safety
Santos, H. O. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad132 · Cited by 15
Pappe, C. L., Steckhan, N., Hoedke, D., Jepsen, S. V., Rauch, G., Keller, T., Michalsen, A., & Dommisch, H. (2021) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13419 · Cited by 15
“In the context of MetS, first clinical studies demonstrated that prolonged (periodic) fasting may exert positive effects in patients with T2DM, obesity, hyperlipidaemia and arterial hypertension (Goldhamer et al., 2001; Papagiannopoulos et al., 2013; Stange et al., 2013; Li et al., 2013, 2017).”
BackgroundSelf-citationZaki, H. A., Iftikhar, H., Abdalrubb, A., Al-Marri, N. D. R., Abdelrahim, M. G., Fayed, M., Elgassim, M. A., & Elarref, M. (2022) · Cureus · doi:10.7759/cureus.30879 · Cited by 21
“(2017) [13] RCT Germany 46 (25-75 years) a low-calorie diet (1200kcal) followed by a 7day fasting period while receiving a daily energy intake of 300kcal Mediterranean diet recorded in the fasting group, while a mean decrease of 2.”
Calorie Restriction and Intermittent Fasting: Impact on Glycemic Control in People With Diabetes
Ganesan, K., Habboush, Y. Y., & Dagogo-Jack, S. E. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0064 · Cited by 17
Yan, S., Wang, C., Zhao, H., Pan, Y., Wang, H., Guo, Y., Yao, N., Li, B., & Cui, W. (2020) · Food & Function · doi:10.1039/d0fo00287a · Cited by 15
Alshammari, K. M., Alhaidal, H. A., Alharbi, R., Alrubaiaan, A., Alyousif, G., Alkaiyat, M., & Abdel-Razaq, W. S. (2023) · Cureus · doi:10.7759/cureus.33920 · Cited by 14
Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study
Ku, M., Ramos, M., & Fung, J. (2017) · Journal of Metabolic Health · doi:10.4102/jir.v2i1.31 · Cited by 19
Lü, L., Chen, X., Liou, S., & Weng, X. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-01039-2 · Cited by 23
Restrictive diets have a beneficial impact on dextran sodium sulfate-induced colitis in male mice
Hadžić, K., Gregor, A., Auernigg‐Haselmaier, S., Longo, V. D., Pignitter, M., & Duszka, K. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.11.005 · Cited by 10
Duron, D. I., Hanak, F., & Streicher, J. M. (2020) · Pain · doi:10.1097/j.pain.0000000000001918 · Cited by 12
“The health benefits of IF havebeen focusedmostly on its positive effects on obesity and metabolic disorders, such as type-2 diabetes.(4,6,29,30) These health benefits have also been extended to improvements in general homeostatic function and cognitive performance,(14,15,21,53) and in many pathological conditions incl…”
BackgroundFasting may be an alternative treatment method recommended by physicians
Armutçu, F. (2019) · Electronic Journal of General Medicine · doi:10.29333/ejgm/104620 · Cited by 14
“There is increasing experimental evidence for positive effects of calorie restriction and IF in type 2 DM. Li et al. (17) claimed that prolonged fasting is practicable and might have useful clinical effects.”
BackgroundChinese Guidelines for Medical Nutrition Therapy for Patients with Diabetes (2022 Edition).
(2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0001 · Cited by 15
Impact of intermittent fasting on body weight in overweight and obese individuals
Lima, C. H. R., Oliveira, I. K. F., Frota, K. D. M. G., de Carvalho, C. M. R. G., Paiva, A. D. A., Campelo, V., & Martins, M. D. C. D. C. E. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.2.222 · Cited by 10
Zeng, X., Ji, Q., Jiang, Z., & Xu, Y. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01492-9 · Cited by 12
“4c [20, 25, 36–38, 40, 42–46, 48, 49].”
BackgroundMethodInfluentialLiu, F., Zhang, Z., Sun, W., & Li, T. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.04.008 · Cited by 10
Lakhani, H. A., Biswas, D., Kuruvila, M., Chava, M. S., Raj, K., Varghese, J. T., & Swathi, N. (2025) · Primary care diabetes · doi:10.1016/j.pcd.2025.02.006 · Cited by 7
Efficacy and safety of modified fasting therapy for weight loss in 2054 hospitalized patients
Liu, T., Ye, Z., Feng, J., Zhang, L., Chen, H., Chen, X., Cai, F., Zhang, G., Lai, J., Ye, Z., et al. (2023) · Obesity · doi:10.1002/oby.23756 · Cited by 9
“Our study found a significant reduction in TG after fasting, and the result was consistent with the conclusions of a previous study [11] and other research [2].”
BackgroundResultHuang, G., Huang, X., & Wei, G. (2025) · Nutrición Hospitalaria · doi:10.20960/nh.05521 · Cited by 13
Gouda, K. M., AbdelHamid, S. G., Mansour, A., Omar, N. N., & EL-Mesallamy, H. O. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030120 · Cited by 6
“It has been observed recently that calorie restriction by means of intermittent fasting and periodic fasting prolongs lifespan and reduces incidence of many age-associated diseases—such as cardiovascular diseases, cancer, kidney diseases and diabetes mellitus (DM) [5].”
BackgroundAnasanti, M. D., & Hamzah, N. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103279 · Cited by 6
Ghashang, S. K., Raha, S., Hamdan, I., Gutenbrunner, C. M., & Nugraha, B. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2019-0209 · Cited by 5
Fasting and metabolic syndrome: A systematic review and Meta-analyses
Li, X., Nian, B., Li, R., Cao, X., Liu, Y., Liu, Y., & Xu, Y.-J. (2024) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2119362 · Cited by 5
“In addition, 2 studies had the comorbidities of type 2 diabetes and one focused on post-menopausal women (Li, Sadraie, et al. 2017; Maifeld et al. 2021).”
BackgroundJiang, Y., Tang, Z., Zhu, X., Xiao, B., Tian, H., Lei, X., Peng, H., Qin, J., Zhang, Y., Hoffman, R. M., et al. (2023) · MedComm · doi:10.1002/mco2.393 · Cited by 6
Intermittent fasting in the treatment of type 2 diabetes
Dyńka, D., Rodzeń, Ł., Rodzeń, M., Łojko, D., Deptuła, A., Grzywacz, Ż., Kraszewski, S., Bartoń, K., Martin, P., Deptuła, A. M., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1629154 · Cited by 11
Matiashova, L., Shanker, A., & Isayeva, G. (2021) · Clinical Diabetology · doi:10.5603/dk.a2021.0016 · Cited by 4
“Li [15] 2017 Low risk Low risk Low risk Low risk Low risk Low risk 6”
BackgroundObservational Study of Lipid Profile and C-Reactive Protein after a Seven-Day Fast
Galetti, V., Brnić, M., Lotin, B., & Frigeri, M. (2021) · Nutrients · doi:10.3390/nu13010255 · Cited by 7
“In another trial, this time with a control group, similar parameters are described at four months after starting a one-week fast in a population suffering from type-2 diabetes [25].”
BackgroundResultChadwick, J., Ayyasamy, L., Kalyanasundaram, M., Ganeshkumar, P., Bagepally, B. S., Jeyashree, K., & Shanmugam, L. (2024) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2024.100249 · Cited by 6
Song, Q., Almutairi, A. S. H., Almutairi, M. F. A., Jamilian, P., & Abu‐Zaid, A. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1664811 · Cited by 7
Koppold, D. A., Michalsen, A., & Hanslian, E. (2024) · Springer eBooks · doi:10.1007/978-3-031-49622-6_10 · Cited by 3
Self-citationFasting Physiology and Therapeutic Diets: A Look Back to the Future.
Bland, J. S. (2019) · PubMed Central · Cited by 4
Dehghani, S., Karimi, P., Tarei, N. N., Masoumvand, M., Manesh, M. A. N., Ramezani, E., & Askari, V. R. (2025) · Current Hypertension Reviews · doi:10.2174/0115734021351456250326051146 · Cited by 7
Fasten – ein potentes Therapeutikum der Moderne
Hanslian, E., Koppold, D. A., & Michalsen, A. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2119-3516 · Cited by 2
“Günstige antidiabetische Effekte für das Heilfasten bei bestehender Erkrankung mit Verbesserung der Glukoseregulation und, bei vorbestehender Insulintherapie, einer Absenkung der Insulindosis belegen 2 kleine randomisierte Studien der eigenen Forschungsgruppe ([32] sowie eine Publikation in Vorbereitung).”
BackgroundSelf-citationDefining Prolonged and Intermittent Fasting: International Consensus on Fasting TerminologyPreprint
Koppold, D. A., Breinlinger, C., Hanslian, E., Keßler, C. S., Cramer, H., Khokhar, A. R., Peterson, C. M., Tinsley, G. M., Vernieri, C., Bloomer, R. J., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4665168 · Cited by 2
Self-citationFasting for male fertility—a mixed methods study
May, K. T., Behling, J., Sochiera-Plegniere, K., Batschari, K., Keßler, C. S., Michalsen, A., Kandil, F. I., Blakeslee, S., Jeitler, M., Stritter, W., et al. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1529466 · Cited by 5
Self-citationUnpacking ketogenic diet impact on diabetes: a systematic review
Gupta, B., Goel, R., Patel, J. S., Gupta, K., & Mittal, A. (2025) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20251424 · Cited by 2
Wang, S., Shi, S., Wu, D., Li, K., Yang, G., Qi, R., Xu, L., Feng, N., Zhong, V. W., & Du, X. (2025) · Food & Function · doi:10.1039/d5fo02781k · Cited by 1
Impact of Nutrition on Somatotroph Axis: A Potential Role in Acromegaly and Its Cardiovascular Risk?
Milioto, A., Gatto, F., Larsson, I., Colao, A. A. L., Ferone, D., Johannsson, G., & Espósito, D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf195 · Cited by 2
“Studies on ER in type 2 DM, though limited by small sample sizes and duration, show increased weight loss but no HbA 1c improvement when compared to nonfasting approaches [110, 111].”
Fasten – ein potentes Therapeutikum der Moderne
Hanslian, E., Koppold, D. A., & Michalsen, A. (2023) · Aktuelle Ernährungsmedizin · doi:10.1055/a-1835-5612 · Cited by 1
“Günstige antidiabetische Effekte für das Heilfasten bei be - stehender Erkrankung mit Verbesserung der Glukose regulation und, bei vorbestehender Insulintherapie, einer Absenkung der Insulindosis belegen 2 kleine randomisier - te Studien der eigenen Forschungsgruppe ([32] sowie eine Publikation in Vorbereitung).”
BackgroundInfluentialSelf-citationNazri, A. F., Soe, M. K. S., & Rasif, M. N. H. A. (2023) · Malaysian Journal of Pharmacy · doi:10.52494/drhi9315 · Cited by 1
Diet as a therapeutic approach to diabetes management and pancreas regeneration
Villani, V., & Perin, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00015-4 · Cited by 2
The effects of intermittent fasting on nighttime blood pressure levels
YÜCE, A. H. Y., Adar, A., Korkut, B., Kalem, P., İnci, H., & Adahan, D. (2022) · Journal of Experimental and Clinical Medicine · doi:10.52142/omujecm.39.3.38 · Cited by 2
Yang, F., Liu, C., Liu, X., Pan, X.-D., Li, X.-Y., Tian, L., Sun, J.-H., Yang, S.-J., Zhao, R., An, N., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-214009/v1 · Cited by 1
“…trial 25:25 Men and women with overweight and obesity ADF: repeatedly alternate between consuming 25% of energy needs over 24- hour Consumed 100% of energy needs every day 24w 46 ± 10 22:3 FM Fi HO Li et al. (2017)[49] Germany A randomized controlled clinical pilot study 23:23 Persons with a…”
BackgroundFasting for Cardiovascular Health
Epstein, E., Maysent, K., & Wilkinson, M. J. (2021) · Contemporary cardiology · doi:10.1007/978-3-030-78177-4_9
Fettleber – das große Potenzial von Ernährungs- und Fastentherapie
Michalsen, A. (2021) · Zeitschrift für Komplementärmedizin · doi:10.1055/a-1410-1522
Self-citationMatiashova, L. (2022) · Ukraïnsʹkij žurnal medicini bìologìï ta sportu · doi:10.26693/jmbs07.01.131
Suplemento do IX Congresso SAMMG
(2021) · Revista Médica de Minas Gerais · doi:10.5935/2238-3182.v31supl.2
Fangying, L. U., ZhiJia, R. U. A. N., Hongda, C. H. E. N., & Qin, J. (2022) · Medical Research · doi:10.6913/mrhk.040304
Impactos do Jejum Intermitente na perda de peso
Torres, M. T., Martins, E. C. B., Pereira, L. N. J., & Kury, C. M. H. (2022) · Revista Científica da Faculdade de Medicina de Campos · doi:10.29184/1980-7813.rcfmc.542.vol.17.n2.2022
Nutritional Principles in the Treatment of Diabetes
Middelbeek, R. J. W., Hafida, S., & Groysman, A. Y. (2023) · Nutrition and health · doi:10.1007/978-3-031-24663-0_5
Efectos metabólicos del ayuno intermitente en pacientes adultos con síndrome metabólico
Chimbo, C. A. M., & Domínguez, G. F. M. (2023) · doi:10.23857/dc.v9i3.3421
BEHAVIORAL PROGRAMS FOR TYPE 2 DIABETES MELITUS: A SYSTEMATIC REVIEW
Hatulely, C. A. (2023) · Journal of Advance Research in Medical & Health Science · doi:10.53555/nnmhs.v9i8.1805
“By focusing on the progression of the disease, the treatment strategy, the content of diabetes education, and its efficacy, we can assist individuals with type 2 diabetes in enhancing their ability to self-manage their condition.(12)”
Background
Metadata
- Authors
- Li, C., Sadraie, B., Steckhan, N., Kessler, C., Stange, R., Jeitler, M., & Michalsen, A.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Immanuel Krankenhaus (DE)
- Corresponding author
- Michalsen, Andreas
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2017-04-13
- Volume
- 125
- Issue
- 09
- Pages
- 618-624
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W2606927981
- Cited by
- 113
- References
- 26
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 13 · 2023: 20 · 2022: 14 · 2021: 16 · 2020: 17 · 2019: 7 · 2018: 3 · 2017: 1
- FWCI
- 5.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
- Keywords
- intermittent fasting, type 2 diabetes, metabolic syndrome, weight loss, abdominal circumference, blood pressure, quality of life, HbA1c, insulin, HOMA-IR, dietary recommendations
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Fasting, Female, Germany, Humans, Male, Middle Aged, Pilot Projects, Time Factors, Treatment Outcome, Metabolic Syndrome, Caloric Restriction, Diet, Mediterranean
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.